JAMA Editor’s Summary

Myocarditis After mRNA-Based COVID-19 Vaccination, Third Dose of BNT161b2 Vaccine and SARS-CoV-2 Infection Incidence, Penetrance of Deleterious Clinical Variants, and more

Editor's Summary by Kristin Walter, MD, Associate Editor of JAMA, the Journal of the American Medical Association, for the issue.

January 25, 2022

Listen on your favorite player Take me to this show’s page

Newer →

Casirivimab and Imdevimab for Early Asymptomatic SARS-CoV-2 Infection, Hypothermia vs Normothermia for Cardiogenic Shock and Extracorporeal Membrane Oxygenation, Familial Idiopathic Dilated Cardiomyopathy, and more

← Older

P2Y12 Inhibitors in Non-Critically Ill Hospitalized COVID-19, US Ambulatory Care Patterns During the Pandemic, Outcomes for Extremely Preterm Infants in the US, and more

Facebook Twitter Buffer LinkedIn WhatsApp

Myocarditis After mRNA-Based COVID-19 Vaccination, Third Dose of BNT161b2 Vaccine and SARS-CoV-2 Infection Incidence, Penetrance of Deleterious Clinical Variants, and more

Editor’s Summary by Kristin Walter, MD, Associate Editor of JAMA, the Journal of the American Medical Association, for the January 25, 2022 issue.

Listen on your favorite player

New to Podcasts? It's easy to get started!

The Latest Health Podcasts. Delivered to Your Inbox.

Join Our Newsletter

JAMA Editor’s Summary

Myocarditis After mRNA-Based COVID-19 Vaccination, Third Dose of BNT161b2 Vaccine and SARS-CoV-2 Infection Incidence, Penetrance of Deleterious Clinical Variants, and more

Newer →

← Older

Myocarditis After mRNA-Based COVID-19 Vaccination, Third Dose of BNT161b2 Vaccine and SARS-CoV-2 Infection Incidence, Penetrance of Deleterious Clinical Variants, and more

Listen on your favorite player

You may also like

The Latest Health Podcasts. Delivered to Your Inbox.

We gratefully acknowledge the many organizations that have generously supported our podcasts and platform.

Network Sponsors and Advertisers

Event and Media Partners

JAMA Editor’s Summary

Myocarditis After mRNA-Based COVID-19 Vaccination, Third Dose of BNT161b2 Vaccine and SARS-CoV-2 Infection Incidence, Penetrance of Deleterious Clinical Variants, and more

Newer →

← Older

Myocarditis After mRNA-Based COVID-19 Vaccination, Third Dose of BNT161b2 Vaccine and SARS-CoV-2 Infection Incidence, Penetrance of Deleterious Clinical Variants, and more

Follow JAMA Editor’s Summary on social!

Listen on your favorite player

You may also like

AAOS Career Podcast

AAOS Advocacy Podcast

AMA Moving Medicine

NEJM This Week – Audio Summaries

The Huddle: Conversations with the Diabetes Care Team

Brain Health News

Better with Doctor Ericka

Ask Nurse Alice

Rethinking Alzheimer’s Disease Podcast

Speak Up For Your Health

Up My Nursing Game

Beyond the Paper Gown

The Latest Health Podcasts. Delivered to Your Inbox.

We gratefully acknowledge the many organizations that have generously supported our podcasts and platform.

Network Sponsors and Advertisers

Event and Media Partners